Integration of dimensional parameters from brain, performance, and self and other-report measures is key towards refining intermediate phenotypes (IPs) within the Research Domain Criteria (RDoC) proposal by NIMH. Currently, IPs do not align well with the disjunctive categorical diagnostic systems. In reality, the symptoms of Major Depressive Disorder (MDD) and Bipolar Disorder (BD) NOS and subthreshold conditions have significant overlap in symptoms and impact. There are likely shared disruptions in cognitive and affective systems (IPs) that may confer risk for these disruptions in negative mood. IPs link genes to brain biology and physiology;IPs also link to subsets of different mood disorder groups. The proposal is a synergistic, integrated and applied series of investigations of core domains in any mood disorders (AMD) for 120 individuals, in remission to diminish state symptom confounds, including all BD, MDD, Mood Disorder, NOS, Adjustment Disorder with Depressed Mood, and subthreshold Mood groups. These AMD subjects will be combined with a healthy control (HC) group of 55 individuals. Domains of the RDoC matrix are measured using self-other- report, other/clinician report, lab-based performance, and brain physiology/circuit (fMRI) biomarker measures to address two Aims and two Exploratory Aims. Scale development tools are used to demonstrate scale reliability and construct validity. Advanced modeling and stratification techniques from biomedical engineering and statistical machine learning will identify across-diagnosis subgroups that share core dimensions of dysfunction, which can be linked to domain and subdomain abnormalities and impact of illness.
Aim 1 studies core (shared) dysfunction in elevated Fear to Acute Threat (1.1) using anxiety measures/Neuroticism facets, emotion processing biases, amygdala and limbic reactivity to negative faces in the Emotion Faces Matching Task, and functional connectivity approaches. There is also a core dysfunction in Loss and Loss anticipation (1.2) using negative environmental loss/stresses, negative memory biases, and NAcc and OFC activation to anticipation of loss in the Monetary Incentive Delay (MID) task, and functional connectivity approaches.
Aim 2 studies core dysfunction in four Cognitive System subdomains, Attention (2.1), Working Memory (2.2), Cognitive Control (Inhibition, 2.3), and Cognitive Control (Interference, 2.4) measured with self and observer reports, performance, and VL and DLPFC and DACC activation in the N-Back and Parametric Go/No-go/Stop tasks during fMRI. An Exploratory Aim in subdomain stability is conducted in 40 AMD stratified on functional outcome plus 20 HC. Exploratory Aim 2 is collection of blood for later targeted gene experiments and/or sharing in larger GWAS studies. In summary, the present proposal uses dimensional modeling anchored in core features of dysfunction across AMD spectrum, but also pursues areas of differentiation based upon diagnosis, domain and functioning. Our strategy is optimal for the study of RDoC dimensional approaches for classification of AMD spectrum by integrating and extending the existing knowledge base, and integrating with commonly used clinical tools and genetic studies for ready translation of novel findings.
Dimensional modeling is a new strategy for helping to resolve how genetics and brain function can be so disparate from current categories of psychiatric illness. The present project uses multimodal, dimensional assessment to capture and subtype, core features across diagnoses, and differentiating biomarkers in all mood disorders, including bipolar, major depressive, mood disorder, adjustment, subthreshold, and NOS categories. Use of these groups and measures from Cognitive and Negative Valence systems provide a full continuum of dimensional data for across modality evaluation of linear, dimensional relationships and determination of construct validity.
|Jacobs, R H; Barba, A; Gowins, J R et al. (2016) Decoupling of the amygdala to other salience network regions in adolescent-onset recurrent major depressive disorder. Psychol Med 46:1055-67|
|Jenkins, Lisanne M; Kassel, Michelle T; Gabriel, Laura B et al. (2016) Amygdala and dorsomedial hyperactivity to emotional faces in youth with remitted Major Depression. Soc Cogn Affect Neurosci 11:736-45|
|Burkhouse, Katie L; Jacobs, Rachel H; Peters, Amy T et al. (2016) Neural correlates of rumination in adolescents with remitted major depressive disorder and healthy controls. Cogn Affect Behav Neurosci :|
|Shankman, Stewart A; Katz, Andrea C; Langenecker, Scott A (2016) Taking an RDoC lens to the study of panic disorder: A commentary on Hamm et al. and other thoughts on RDoC. Psychophysiology 53:328-31|
|Kassel, Michelle T; Rao, Julia A; Walker, Sara J et al. (2016) Decreased Fronto-Limbic Activation and Disrupted Semantic-Cued List Learning in Major Depressive Disorder. J Int Neuropsychol Soc 22:412-25|
|Jenkins, Lisanne Michelle; Barba, Alyssa; Campbell, Miranda et al. (2016) Shared white matter alterations across emotional disorders: A voxel-based meta-analysis of fractional anisotropy. Neuroimage Clin 12:1022-1034|
|Peters, Amy T; Van Meter, Anna; Pruitt, Patrick J et al. (2016) Acute cortisol reactivity attenuates engagement of fronto-parietal and striatal regions during emotion processing in negative mood disorders. Psychoneuroendocrinology 73:67-78|
|Rao, Julia A; Jenkins, Lisanne M; Hymen, Erica et al. (2016) Differential Resting State Connectivity Patterns and Impaired Semantically Cued List Learning Test Performance in Early Course Remitted Major Depressive Disorder. J Int Neuropsychol Soc 22:225-39|
|Peters, Amy T; Jacobs, Rachel H; Crane, Natania A et al. (2015) Domain-specific impairment in cognitive control among remitted youth with a history of major depression. Early Interv Psychiatry :|
|Ryan, Kelly A; Dawson, Erica L; Kassel, Michelle T et al. (2015) Shared dimensions of performance and activation dysfunction in cognitive control in females with mood disorders. Brain 138:1424-34|
Showing the most recent 10 out of 14 publications